Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001193125-25-256847
Filing Date
2025-10-29
Accepted
2025-10-29 18:03:09
Documents
2
Period of Report
2025-10-29

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1604
2 EX-24 ck0002029769-ex24.htm EX-24 10828
  Complete submission text file 0001193125-25-256847.txt   13923
Mailing Address 333 SOUTH GRAND AVENUE, 28TH FLOOR LOS ANGELES CA 90071
Business Address 333 SOUTH GRAND AVENUE, 28TH FLOOR LOS ANGELES CA 90071 213-830-6300
Oaktree Acquisition Corp. III Life Sciences (Issuer) CIK: 0002029769 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 6770 Blank Checks
(CF Office: 05 Real Estate & Construction)

Mailing Address C/O OAKTREE CAPITAL MANAGEMENT, L.P. 333 S. GRAND AVENUE, 28TH FLOOR LOS ANGELES CA 90071
Business Address
Martinez George Arthur (Reporting) CIK: 0002093176 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-42383 | Film No.: 251431414